Expert Opinion on Drug Safety

SJR Rank #6,194H-index: 101SJR: 0.860Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Medicine (miscellaneous)Q2
  • Pharmacology (medical)Q2

Areas: Medicine

Most published research topics

Pharmacovigilance and Adverse Drug ReactionsDrug-Induced Adverse ReactionsDiabetes Treatment and ManagementRheumatoid Arthritis Research and TherapiesPharmaceutical studies and practicesPharmacological Effects and Toxicity StudiesPregnancy and Medication ImpactSchizophrenia research and treatmentLipoproteins and Cardiovascular HealthPharmaceutical Practices and Patient Outcomes

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025080160240320

Detailed Information

ISSN

1474-0338, 1744-764X

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

3.09

References per Document

42.76

Coverage

2002-2026

Scope

Expert Opinion on Drug Safety ranks #62 of 216 in the Pharmacology & Pharmacy category in the 2008 ISI Journal Citation Reports. Expert Opinion on Drug Safety (ISSN 1474-0338 [print], 1744-764X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of drug safety and original papers on the clinical implications of drug treatment safety issues, providing expert opinion on the scope for future development.

Metrics from SCImago Journal Rank 2025. View on SCImago